One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Prosthetic Heart Valve Market

[ 英語タイトル ] Prosthetic Heart Valve Market- Growth, Trends, and Forecast (2020 - 2025)


Product Code : MDHC0089149
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 111
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Medtronic PLC
- Edwards Lifesciences Corporation
- Boston Scientific Corporation
- Livanova PLC
- St. Jude Medical Inc. (An Abbott Laboratories Company)
- Symetis SA
- Jenavalve Technology Inc.
- Cryolife Inc.
- TTK Healthcare Limited
- Colibri Heart Valve LLC
- Lepu Medical Technology Co. Ltd

[Report Description]

The prosthetic heart valve market will show rapid growth due to the subsequent growth in the prevalence of heart valve disease and rising regulatory approvals for a new and advanced prosthetic heart valve.

Valvular heart disease (VHD) places a significant burden on the global healthcare system. According to the American College of Cardiology, there are approximately 5 million Americans that are being diagnosed with HVD every year. VHD mainly affects the older population as a result of calcium buildup and scarring in the valve cusp due to ageing. The prevalence of VHD in the population aged 18-44 and 75 years was 0.7% and 13.0%, respectively in 2012. Therefore the rapid growth in the ageing population and the consequent rise in the prevalence of VHD is expected to drive the market growth for the prosthetic heart valve market.

The prosthetic valves market has also witnessed several clinical trials in recent years especially in the European countries due to uniform regulations and high prevalence of heart diseases.

Key Market Trends

Transcatheter Heart Valve Segment is Expected to Register Robust Growth During the Forecast Period

The transcatheter heart valve segment is expected to hold a significant share in the global market and the large share can be attributed to the various factors such as ease of implantation, rise in the number of transcatheter heart valve surgery centres and growing of the patient population. There are also growth opportunities in emerging countries and the use of transcatheter heart valves for new indications (treatment of intermediate-risk patients and high-risk patients) are thus expected to provide numerous opportunities for the market growth during the forecast period.

In addition, the rise in adoption rate for transcatheter heart valve implantation procedure and new device approvals are expected to lead the growth of transcatheter heart valve market.

North America is Found to be the Largest Market for the Prosthetic Heart Valve

North America is expected to dominate the prosthetic heart valve market, followed by Europe, Asia-Pacific, and the rest of the world. North America contributes to the largest market share due to the rapid growth in the ageing population and the high prevalence of valvular heart diseases. Furthermore, the favourable reimbursement scenario and rising product approvals for the heart valve are also contributing to the growth of the North American prosthetic heart valve market.

The Asia Pacific is also expected to witness the high growth in the next few years, due to the growing incidences of chronic diseases and increasing disposable income.

Competitive Landscape

A majority of the leading players in this market are focusing on marketing and promotional activities, product launches and approvals, acquisitions, agreements, collaborations, and expansions to enhance their market presence and strengthen their distribution networks, cater to the needs of a growing customer base, widen their product portfolios, and boost their production capabilities.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Heart Valve Disease
4.2.2 Rising Regulatory Approvals for New and Advanced Prosthetic Heart Valve
4.3 Market Restraints
4.3.1 High Cost of Transcatheter Aortic Valve Replacement (TAVR) Procedures
4.3.2 Availability of Alternative Methods for Treating Heart Valve Diseases (HVD)
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type of Valve
5.1.1 Mechanical Heart Valve
5.1.2 Bioprosthetic Heart Valve
5.1.3 Transcatheter Heart Valve
5.2 By Position
5.2.1 Mitral Valve
5.2.2 Aortic Valve
5.2.3 Other Positions
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Edwards Lifesciences Corporation
6.1.3 Boston Scientific Corporation
6.1.4 Livanova PLC
6.1.5 St. Jude Medical Inc. (An Abbott Laboratories Company)
6.1.6 Symetis SA
6.1.7 Jenavalve Technology Inc.
6.1.8 Cryolife Inc.
6.1.9 TTK Healthcare Limited
6.1.10 Colibri Heart Valve LLC
6.1.11 Lepu Medical Technology Co. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+